15/10/2019 – 18/10/2019
ILSI Europe sessions are jointly organised by the Food Safety and Nutrition Task Forces:
– Qualitative Fat Intake
– Nutrient Intake Optimisation
– Early-Life Nutrition and Long-Term Health
– Nutrition and Mental Performance
– Dietary Carbohydrates
– Obesity and Diabetes
– Dietary Intake and Exposure
– Consumer Behaviour Determinants
1. From early-life events to the ageing brain: Impact of nutrition on health determinants
2. New methodologies for food intake and dietary exposure assessment
3. An update on ILSI’s Europe activities on Glycaemic Exposure: from the population without diabetes to Gestational Diabetes Mellitus.
4. An Update on the Beneficial Health Impact of Specific Dietary Fatty Acids
5. Understanding Consumer Choice Drivers to Achieve Sustainable Food and Nutrition Security
6. Unlocking the potential of the microbiome
Session 1: From early-life events to the ageing brain: Impact of nutrition on health determinants
The aim of this session is to provide an overview of ILSI Europe’s activities related to the impact of nutrition on health during the lifespan.
Environmental and nutritional factors may impact long-term effects on brain and behaviour. Hence, there is probably a key role for nutrition in influencing health and well-being already early in life, also through microbiota-mediated effects. The first talk will provide insights into the role of gut microbiota in programming health and disease during the early stages of life. Since microbial imbalance plays a role in sub-optimal human metabolism, and is linked to impaired immune and brain functions associated with ageing, the second talk will highlight many dietary components that may prevent, or reduce the severity of age-related functional decline and the onset of unfavourable health. The session will end with an overview of the impact of nutrition on the ageing brain with a focus on whether diet and nutrients have efficacy in individuals affected by dementia and other neurodegenerative conditions.
Session 2: New methodologies for food intake and dietary exposure assessment
The aim of this session is to highlight ILSI Europe’s activities in establishing the links between various components of the food, their optimal intake levels and public health. The first talk will evaluate the potential for incorporating data on Occurrence and Consumer Loyalty into dietary exposure models. The second speaker will review the latest improvements in dietary intake assessment methodologies. The final talk will provide an overview of the latest advancements in the identification and validation of markers for glycaemia for the non-diabetic population.
Session 3: An update on ILSI’s Europe activities on Glycaemic Exposure: from the population without diabetes to Gestational Diabetes Mellitus
The aim of this session is to highlight ILSI Europe’s on Glycaemic Exposure. The first talk will focus on the health Impact of Reducing Post-Prandial Glycaemia via drug or diet intervention. The second talk will review the efficacy of type 2 diabetes markers in evaluating the effectiveness of food intervention in non-diabetic population. Finally, we will provide insights into how food intervention could influence Gestational Diabetes Mellitus.
Session 4: An Update on the Beneficial Health Impact of Specific Dietary Fatty Acids
The aim of this session is to highlight ILSI Europe’s activities on the beneficial impact of specific dietary fatty acids on human health. The talks will provide an overview of the health impact of diets rich in Omega-3 and Omega -6 (talk 1), specific saturated fatty acids (talk 2) or ω -3 and ω -6 (talk 3).
Session 5: Understanding Consumer Choice Drivers to Achieve Sustainable Food and Nutrition Security
Unhealthy food choices and related behaviours are currently driving increased rates of obesity in Europe, with concomitant increases in the incidence of non-communicable diseases. Approaches such as Nudging, the Nutri and PEF-score, policy instruments and personalized nutrition are being widely adopted as a measure to encourage healthier consumer food choices, although there is mixed evidence to support its use as a behavioural intervention, in particular in terms of long term dietary changes. In addition, various theoretical approaches and methodological perspectives have been retrospectively aggregated under the “nudging” umbrella, in the absence of a formalised definition or theoretical perspective on what nudging actually represents. The proposed session aims to discuss the existing evidence base regarding the short and long term impacts of nudging, and to identify gaps in knowledge where these exist.
Session 6: Unlocking the potential of the microbiome
ILSI Europe Session ‘Unlocking the potential of the microbiome’ explores the role gut and oral microbiome play in human health and chronic diseases such as obesity and diabetes. The three talks provide insights into the impact of diet on intestinal microbiome and its metabolism as well as discuss possibilities nutritional interventions offer for shaping gut microbiome beneficially. This includes presentation of guidelines facilitating the design and conduct of human gut microbiome intervention studies relating to foods developed by ILSI Europe ‘Food health benefits assessment’ Task Force. Oral microbiota, its resilience and the impact of this to systemic health will be covered, too
Gut and oral microbiota contribute significantly to mammalian biocomplexity, its health and disease. Cross-talk exists between the microbiota and host through a variety of mechanisms, not to mention the extraordinary metabolic potential, which the intestinal microbiota has. Perturbations in microbiota composition are associated with obesity, diabetes and allergies, but are also detected at the onset of several other non-pathogenic chronic diseases. Oral microbiota, too, is increasingly explored as a contributor to systemic diseases. The increasing understanding on the role of microbiota in defining health, coupled with the accessibility of this malleable population for dietary manipulation makes it an attractive target for improving human health and reducing disease.
For more information on the sessions, please contact Dr Lucie Geurts, Scientific Project Manager.